[Effect of rosiglitazone on cells cycle, apoptosis and expression of Skp2 and p27Kip1 in hepatocellular carcinoma cell line].
Peng
Li
L
Department of Hepatobiliary Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China. pengli72@sina.com
Xu
Zhuo
Z
Zhou
Ye
Y
Yang
Tao
T
Liang
Zhan-qiang
ZQ
Zhang
Meng
M
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D006528:Carcinoma, Hepatocellular / Q000378:metabolism / Q000473:pathology*; D002453:Cell Cycle / Q000187:drug effects*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D050760:Cyclin-Dependent Kinase Inhibitor p27 / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D008113:Liver Neoplasms / Q000378:metabolism / Q000473:pathology*; D051059:PTEN Phosphohydrolase / Q000378:metabolism; D000077154:Rosiglitazone; D044786:S-Phase Kinase-Associated Proteins / Q000378:metabolism; D045162:Thiazolidinediones / Q000494:pharmacology*
D000970:Antineoplastic Agents; D044786:S-Phase Kinase-Associated Proteins; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D050760:Cyclin-Dependent Kinase Inhibitor p27; D051059:PTEN Phosphohydrolase